ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018837
  Purpose

The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.


Condition Intervention
Schizophrenia
Schizophrenic Disorder
Behavioral: Community Re-Entry Program: What is Schizophrenia

MedlinePlus related topics:   Schizophrenia   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Educational/Counseling/Training, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title:   Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Further study details as provided by Department of Veterans Affairs:

Study Start Date:   April 1998
Estimated Study Completion Date:   March 2001

  Eligibility
Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  1. Age 18-65 years of age.
  2. DSM IV diagnosis of schizophrenia or schizoaffective disorder.
  3. Competent to give informed consent.
  4. Previously participated in "Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome" Principal Investigator. Donna Wirshing, M.D.

Exclusion Criteria:

  1. Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent.
  2. History of substantial substance dependence 6 months prior to the study.
  3. Patients at high risk of suicide or other directed violence.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018837

Locations
United States, California
VA Greater Los Angeles Healthcare System    
      Los Angeles, California, United States, 90073

Sponsors and Collaborators
  More Information


Study ID Numbers:   MHBS-010-98S
First Received:   July 3, 2001
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00018837
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers